The nuclear receptor peroxisomeproliferator-activated receptor gamma (PPARγ) regulates transcription of various genes involved inlipid uptake, fatty acid metabolism, and glucose homeostasis [1], therefore, themodulation of PPARγ action is of intenseinterests in the medication of insulin resistance and related metabolic disorders[2–7]. This evidence concerns the gene PPARG and metabolic disease.